VanEck Vectors Valuation

VanEck Vectors Biotech ETF -- USA Etf  

USD 128.83  0.49  0.38%

VanEck Vectors Biotech has current Real Value of $120.05 per share. The regular price of the etf is $128.83. At this time the etf appears to be over valued. Macroaxis measures value of VanEck Vectors Biotech from inspecting the etf fundamentals such as Number of Employees of 6, Five Year Return of 18.69% and Price to Earning of 17.66times as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securites prices and their ongoing real values will draw towards each other.
 Time Horizon     30 Days    Login   to change
VanEck Vectors Biotech ETF is third largest ETF in price to sales as compared to similar ETFs. It is rated below average in one year return as compared to similar ETFs reporting about  3.49  of One Year Return per Price to Sales.
Over Valued
January 20, 2018
Market Value
Downside upside
Real Value
Target Price Odds
 Above  Below  
Upside upside
VanEck Vectors is not too risky asset. Calculation of real value of VanEck Vectors Biotech is based on 1 month time horizon. Increasing VanEck Vectors Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Net Asset

VanEck Vectors Net Asset Analysis
VanEck Vectors Biotech ETF is rated below average in net asset as compared to similar ETFs. Total Asset Under Management (AUM) of Health category is currently estimated at about 42.9 Billion. VanEck Vectors claims roughly 591.53 Million in net asset contributing just under 2% to all ETFs under Health category.